Stay updated on GEMINI 1 Tolebrutinib Clinical Trial
Sign up to get notified when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.

Latest updates to the GEMINI 1 Tolebrutinib Clinical Trial page
- CheckyesterdayChange DetectedLocations section updated with additions and deletions of multiple study sites across the US, Canada, and other countries, altering the geographic footprint of the trial. This may impact where participants can enroll and how the study is accessed.SummaryDifference2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedThe Publications section now notes that PubMed publications are automatically filled from PubMed and includes Revision: v3.3.1; the older manual PubMed listing language and Revision: v3.2.0 were removed.SummaryDifference0.0%

- Check39 days agoChange DetectedRemoved the government funding status banner informing users that information may not be up to date due to a lapse in funding. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedResults for NCT04410978 GEMINI 1 were posted on ClinicalTrials.gov, including the NEJM 2025 publication by Oh et al.; the page now lists updated outcome measures and key study dates.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to GEMINI 1 Tolebrutinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.